| Molecular formula | C29H39N5O7 |
|---|
| Molecular weight | 569.6 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 10099522 |
|---|
Key takeaways
- Pentapeptide-18 has no FDA-approved label or brand name.
- It is classified as an unapproved research compound, not a marketed drug.
- No registered clinical trials for pentapeptide-18 were found in the data reviewed.
- Its molecular formula is C29H39N5O7, with a molecular weight of about 569.6 g/mol.
What pentapeptide-18 is
Pentapeptide-18 is a synthetic peptide identified by PubChem CID 10099522. It has a molecular weight of approximately 569.6 g/mol and the molecular formula C29H39N5O7. No FDA-approved label exists for this compound, so there is no established mechanism, indication, or dosing information from regulatory sources.
Trial footprint
The data reviewed show no registered clinical trials for pentapeptide-18. This means there is no publicly tracked trial activity to summarize at this time.
FAQ
No. Pentapeptide-18 has no FDA-approved label, indication, or brand name. It is classified as an unapproved research compound.
Pentapeptide-18 is a synthetic peptide with the molecular formula C29H39N5O7. It has a molecular weight of about 569.6 g/mol, based on its PubChem record.
Based on the data reviewed, no registered clinical trials for pentapeptide-18 were found. This means there is currently no publicly tracked trial activity to reference.
Pentapeptide-18 is listed under PubChem CID 10099522. This identifier can be used to look up its chemical structure and properties in public databases.
No adverse event report data is available for pentapeptide-18 in the sources reviewed. Because it lacks an approved label, there is no established safety profile.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem
Updated 2026-08-04